Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction

Emanuel Zitt; Denis Fouque; Stefan H Jacobson; Fabio Malberti; Miroslav Ryba; Pablo Ureña; Marianne Rix; Bastian Dehmel; Nick Manamley; Marc Vervloet

doi:10.1093/ckj/sft026

Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction

Emanuel Zitt
, Denis Fouque
, Stefan H Jacobson
, Fabio Malberti
, Miroslav Ryba
, Pablo Ureña
, Marianne Rix
, Bastian Dehmel
, Nick Manamley
, Marc Vervloet

23 Citationer (Scopus)

Abstract

The calcimimetic cinacalcet lowers parathyroid hormone (PTH), calcium (Ca) and phosphorus (P) in dialysis patients with secondary hyperparathyroidism (SHPT). We explored serum P changes in dialysis patients treated with cinacalcet, while controlling for vitamin D sterol and phosphate binder (PB) changes, based on data from the pan-European observational study ECHO.

Originalsprog	Engelsk
Tidsskrift	Clinical kidney journal
Vol/bind	6
Udgave nummer	3
Sider (fra-til)	287-294
Antal sider	8
ISSN	2048-8505
DOI	https://doi.org/10.1093/ckj/sft026
Status	Udgivet - jun. 2013

Adgang til dokumentet

10.1093/ckj/sft026

Citationsformater

@article{98a22b2bdf084df6982ebb5c432802df,

title = "Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction",

abstract = "The calcimimetic cinacalcet lowers parathyroid hormone (PTH), calcium (Ca) and phosphorus (P) in dialysis patients with secondary hyperparathyroidism (SHPT). We explored serum P changes in dialysis patients treated with cinacalcet, while controlling for vitamin D sterol and phosphate binder (PB) changes, based on data from the pan-European observational study ECHO.",

author = "Emanuel Zitt and Denis Fouque and Jacobson, \{Stefan H\} and Fabio Malberti and Miroslav Ryba and Pablo Ure{\~n}a and Marianne Rix and Bastian Dehmel and Nick Manamley and Marc Vervloet",

year = "2013",

month = jun,

doi = "10.1093/ckj/sft026",

language = "English",

volume = "6",

pages = "287--294",

journal = "Clinical kidney journal",

issn = "2048-8505",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction

AU - Zitt, Emanuel

AU - Fouque, Denis

AU - Jacobson, Stefan H

AU - Malberti, Fabio

AU - Ryba, Miroslav

AU - Ureña, Pablo

AU - Rix, Marianne

AU - Dehmel, Bastian

AU - Manamley, Nick

AU - Vervloet, Marc

PY - 2013/6

Y1 - 2013/6

N2 - The calcimimetic cinacalcet lowers parathyroid hormone (PTH), calcium (Ca) and phosphorus (P) in dialysis patients with secondary hyperparathyroidism (SHPT). We explored serum P changes in dialysis patients treated with cinacalcet, while controlling for vitamin D sterol and phosphate binder (PB) changes, based on data from the pan-European observational study ECHO.

AB - The calcimimetic cinacalcet lowers parathyroid hormone (PTH), calcium (Ca) and phosphorus (P) in dialysis patients with secondary hyperparathyroidism (SHPT). We explored serum P changes in dialysis patients treated with cinacalcet, while controlling for vitamin D sterol and phosphate binder (PB) changes, based on data from the pan-European observational study ECHO.

U2 - 10.1093/ckj/sft026

DO - 10.1093/ckj/sft026

M3 - Journal article

C2 - 23717787

SN - 2048-8505

VL - 6

SP - 287

EP - 294

JO - Clinical kidney journal

JF - Clinical kidney journal

IS - 3

ER -

Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater